Autor: |
Ye Qiu, An-lin Liu, Jie Huang, Wen Zeng, Zhen-ming Yang, Gao-neng Fang, Ya Li, Yu-zhuo Zhang, Jin-kai Liang, Jiong Liu, Shu-hong Liao, Xiao-xue Cheng, Yi-jun Chen, Feng Ye, Zheng-tu Li, Jian-quan Zhang |
Jazyk: |
angličtina |
Rok vydání: |
2023 |
Předmět: |
|
Zdroj: |
International Journal of Infectious Diseases, Vol 132, Iss , Pp 93-98 (2023) |
Druh dokumentu: |
article |
ISSN: |
1201-9712 |
DOI: |
10.1016/j.ijid.2023.04.398 |
Popis: |
Objectives: Talaromyces marneffei is an emerging pathogen, and the number of infections in HIV-negative individuals is rapidly increasing. Nevertheless, there is no sufficient comprehensive report on this issue, and awareness needs to be raised among clinicians. Methods: We analyzed the differences in the clinical data of patients who are HIV-negative and HIV-positive with Talaromyces marneffei infection (TMI) from 2018 to 2022. Results: A total of 848 patients were included, among whom 104 were HIV-negative. The obvious differences between the HIV-positive and HIV-negative groups were as follows: (i) the patients who are HIV-negative were older and more likely to exhibit cough and rash, (ii) the time in days from symptom onset to diagnosis among patients who are HIV-negative was longer, (iii) the laboratory findings and radiological presentations seemed more severe in patients who are HIV-negative, (iv) differences were observed regarding the underlying conditions and co-infection pathogens, and correlation analysis showed that correlations existed for many indicators, (v) and persistent infection was more likely to occur in patients who are HIV-negative. Conclusion: TMI in patients who are HIV-negative differs from that in patients who are HIV-positive in many aspects, and more investigations are needed. Clinicians should be more aware of TMI in patients who are HIV-negative. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|